DDI active wash-out [Design Issues]

posted by Dr_Dan  – Germany, 2015-01-09 16:59 (4183 d 18:21 ago) – Posting: # 14268
Views: 9,331

Dear nobody
You are completely right, but my question is a little bit different. I start my my study with Treatment C, 5 days dosing drug 1 = steady state drug 1. Next step Treatment B, 14 days dosing drug 2 = steady state drug 2. Then I will administer the combination product. But for how long? For drug 1 I need 5 days and for drug 2 I am already at steady state. If I consider the formulation effect I would need to dose 14 days, but is this necessary?
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
115 visitors (1 registered, 114 guests [including 11 identified bots]).
Forum time: 12:21 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5